Montserrat Gutierrez-Gomez
Caceres, EX, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: April 05, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge.
Journal: Journal of personalized medicine
Published: February 25, 2026
Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease.
Journal: Frontiers in neurology
Published: February 16, 2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Journal: Therapeutic advances in neurological disorders
Published: January 14, 2026
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management.
Journal: Therapeutic advances in neurological disorders
Published: April 12, 2024
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 14, 2024
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.
Journal: Patient preference and adherence
Published: January 12, 2024
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: January 03, 2024
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Journal: Neurology and therapy
Published: May 29, 2023
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.
Journal: Neurologia
Published: March 09, 2023
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 23, 2018
A stroke care management system prevents outcome differences related to time of stroke unit admission.
Journal: Neurologia (Barcelona, Spain)
Published: November 03, 2014
Last Updated: 09/26/2026